Nutex Health (NUTX) Director Michael Reed Receives 603 Shares

What Happened
Michael Reed, a director of Nutex Health (NUTX), acquired 603 shares on July 31, 2026 through the conversion/exercise of a derivative (reported with code M). The shares were obtained at $0.00 per share (total reported transaction value $0), reflecting a conversion of restricted stock units into common stock rather than an open-market purchase.

Key Details

• Transaction date: 2026-07-31; Filing date: 2026-08-03 (as reported).
• Transaction type/code: M — exercise or conversion of a derivative (here, RSUs converting to common shares).
• Shares acquired: 603 common shares at $0.00 per share (total $0 reported).
• Footnote F1: Restricted stock units convert into common shares on a one-for-one basis.
• Footnote F2: The Michael L Reed Trust IRA (MLRTIRA) directly owns 67 shares; Michael L. Reed is the indirect beneficial owner of those shares as sole trustee.
• The filing does not indicate any immediate sale of the shares after conversion.

Context
This transaction represents an acquisition via vesting/conversion of equity compensation (RSUs), not a market buy or sale. Such conversions are common as RSUs vest and are generally administrative/compensation events; they do not necessarily signal the insider’s view on the stock. No indication was provided that the shares were sold immediately (i.e., this was not a cashless exercise or sale).